Expression, Purification, and Application of SARS-CoV-2 Nucleocapsid Protein for Serological Detection of IgG and IgM Antibodies
Open Access
- 17 February 2026
- journal article
- Published by Knowledge E DMCC in Avicenna Journal of Medical Biotechnology
- Vol. 18 (1) , 55-60
Abstract
Background: SARS-CoV-2 is a novel coronavirus that has caused dramatic loss of life and poses an unprecedented public health challenge worldwide. The nucleocapsid (N) protein of SARS-CoV-2 is the most abundant viral protein and a potent immunogen. Methods: In the current study, the N gene of SARS-CoV-2 was amplified from RNA extracted from a COVID-19 positive patient and then cloned into the pCold-I expression vector. The full-length His-tagged N protein was expressed in Escherichia coli (E. coli) using 0.5 mM IPTG and subsequently purified by nickel affinity chromatography. The purified N protein was characterized using sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and Western blotting. Furthermore, the purified N protein was applied in SARS-CoV-2 IgG and IgM ELISA immunoassays. Results: The results showed that purification of the N protein in the presence of urea yielded a protein band of approximately 48 kDa on SDS-PAGE, corresponding to the full-length N protein. Additionally, Western blot analysis of the purified recombinant N protein showed a band of the same molecular weight. In the SARS-CoV-2 IgG ELISA assay, anti-N protein antibodies from a COVID-19 positive patient’s serum successfully recognized the coated N protein. In the IgM ELISA test, an N-HRP conjugate was used in ELISA wells to reveal the interaction of HRP-conjugated N protein with pre-coated anti-N protein antibodies (IgM isotype). Conclusion: These results indicate that the expressed N protein of SARS-CoV-2 could serve as a valuable reagent for the development of antibody-based immunoassays to detect SARS-CoV-2 IgG and IgM antibodies.Keywords
This publication has 17 references indexed in Scilit:
- Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2Virology, 2021
- Development of a Nucleocapsid Protein-Based ELISA for Detection of Human IgM and IgG Antibodies to SARS-CoV-2ACS Omega, 2021
- Identification and functional analysis of the SARS-COV-2 nucleocapsid proteinBMC Microbiology, 2021
- Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coliDiagnostics, 2021
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challengesInternational Journal of Antimicrobial Agents, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- The human antibody response to influenza A virus infection and vaccinationNature Reviews Immunology, 2019
- An endogenous ‘non-specific’ protein detected by a His-tag antibody is human transcription regulator YY1Data in Brief, 2015
- Recombinant viral proteins for use in diagnostic ELISAs to detect virus infectionVaccine, 2007
- Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccinationApplied Microbiology and Biotechnology, 2005